Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic
- PMID: 19326705
Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic
Abstract
Background & objectives: During 2006, chikungunya emerged as a major ever known epidemic in India. Disability adjusted life years (DALY) is an appropriate summary measure of population health to express epidemiological burden of diseases. We estimated the burden due to suspected chikungunya using DALYs for the first time and compared between the states and also with the burden due to other vector-borne diseases in India. The economic burden was also assessed in terms of productivity loss.
Methods: Data on the reported cases of fever/suspected cases of chikungunya from different states during 2006 in India were used. Years lived with disability (YLD) were calculated for non-fatal cases to estimate DALY. Since the disability weight for chikungunya is not available, the weights available for rheumatic arthritis, comparable to the disease outcome of chikungunya were used for the estimation. The burden was estimated for both acute and chronic cases. It is considered that about 11.5% of cases were reported to have extended morbidity with persisting arthralgia. For acute disease, the average duration of illness was considered to be nine days and for chronic cases it was six months on an average. The productivity loss due to income foregone by the working class was calculated using minimum official wage.
Results: National burden of chikungunya was estimated to be 25,588 DALYs lost during 2006 epidemic, with an overall burden of 45.26 DALYs per million. It varied from 0.01 to 265.62 per million in different states. Karnataka alone contributed as high as 55% of the national burden. Persistent arthralgia was found to impose heavy burden, accounting for 69% of the total DALYs. The productivity loss in terms of income foregone was estimated to be a minimum of Rs. 391 million.
Interpretation & conclusion: The chikungunya epidemic in the year 2006 imposed heavy epidemiological burden and productivity loss to the community. The burden of chikungunya in terms of DALY was estimated for the first time. In view of re-emergence and spread of this infection in recent times it is warranted for derivation of disability weight for different health states of chikungunya to facilitate realistic estimates of DALYs. Quality epidemiological data from surveillance system to monitor vector-borne and zoonotic diseases would pave way for more realistic estimates of burden. The productivity loss in-terms of income foregone could be minimal as the estimation was made by using the minimum wage fixed by the government although the actual loss is expected to be higher.
Similar articles
-
Estimating the burden of disease and the economic cost attributable to chikungunya, Andhra Pradesh, India, 2005-2006.Trans R Soc Trop Med Hyg. 2010 Feb;104(2):133-8. doi: 10.1016/j.trstmh.2009.07.014. Epub 2009 Aug 25. Trans R Soc Trop Med Hyg. 2010. PMID: 19709705
-
Cost of illness due to Chikungunya during 2006 outbreak in a rural area in Tamil Nadu.Indian J Public Health. 2009 Oct-Dec;53(4):209-13. Indian J Public Health. 2009. PMID: 20469756
-
Economic consequences of HIV/AIDS in India.Natl Med J India. 1997 Jan-Feb;10(1):27-30. Natl Med J India. 1997. PMID: 9069706
-
Chikungunya epidemic: an Indian perspective.Natl Med J India. 2006 Nov-Dec;19(6):315-22. Natl Med J India. 2006. PMID: 17343016 Review.
-
Chikungunya epidemic: global and Indian scenario.J Commun Dis. 2007 Mar;39(1):37-43. J Commun Dis. 2007. PMID: 18338715 Review.
Cited by
-
Chikungunya virus and prospects for a vaccine.Expert Rev Vaccines. 2012 Sep;11(9):1087-101. doi: 10.1586/erv.12.84. Expert Rev Vaccines. 2012. PMID: 23151166 Free PMC article. Review.
-
Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study.Am J Trop Med Hyg. 2018 Jul;99(1):182-190. doi: 10.4269/ajtmh.17-0543. Epub 2018 May 24. Am J Trop Med Hyg. 2018. PMID: 29848408 Free PMC article.
-
Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.J Infect Dis. 2014 Jun 15;209(12):1891-9. doi: 10.1093/infdis/jiu014. Epub 2014 Jan 7. J Infect Dis. 2014. PMID: 24403555 Free PMC article.
-
Epidemiology and Economic Burden of Chikungunya: A Systematic Literature Review.Trop Med Infect Dis. 2023 May 31;8(6):301. doi: 10.3390/tropicalmed8060301. Trop Med Infect Dis. 2023. PMID: 37368719 Free PMC article. Review.
-
Cytokine and T cell responses in post-chikungunya viral arthritis: A cross-sectional study.PLoS One. 2024 Mar 20;19(3):e0299521. doi: 10.1371/journal.pone.0299521. eCollection 2024. PLoS One. 2024. PMID: 38507338 Free PMC article.
MeSH terms
LinkOut - more resources
Medical